Visceral fat in hypertension: influence on insulin resistance and beta-cell function - PubMed (original) (raw)
Clinical Trial
Visceral fat in hypertension: influence on insulin resistance and beta-cell function
Anna Maria Sironi et al. Hypertension. 2004 Aug.
Erratum in
- Hypertension. 2004 Nov;44(5):e8. Postano, Vincenzo [corrected to Positano, Vincenzo]
Abstract
Preferential visceral adipose tissue (VAT) deposition has been associated with the presence of insulin resistance in obese and diabetic subjects. The independent association of VAT accumulation with hypertension and its impact on insulin sensitivity and beta-cell function have not been assessed. We measured VAT and subcutaneous fat depots by multiscan MRI in 13 nondiabetic men with newly detected, untreated essential hypertension (blood pressure=151+/-2/94+/-2 mm Hg, age=47+/-2 years, body mass index [BMI]=28.4+/-0.7 kg x m(-2)) and 26 age-matched and BMI-matched normotensive men (blood pressure=123+/-1/69+/-2 mm Hg). Insulin secretion was measured by deconvolution of C-peptide data obtained during an oral glucose tolerance test, and dynamic indices of beta-cell function were calculated by mathematical modeling. For a similar fat mass in the scanned abdominal region (4.8+/-0.3 versus 3.9+/-0.3 kg, hypertensive subjects versus controls, P=0.06), hypertensive subjects had 60% more VAT than controls (1.6+/-0.2 versus 1.0+/-0.1 kg, P=0.003). Intrathoracic fat also was expanded in patients versus controls (45+/-5 versus 28+/-3 cm2, P=0.005). Insulin sensitivity was reduced (10.7+/-0.7 versus 12.9+/-0.4 mL x min(-1) x kg(ffm)(-1), P=0.006), and total insulin output was proportionally increased (64 [21] versus 45 [24] nmol x m(-2). h, median [interquartile range], P=0.01), but dynamic indices of beta-cell function (glucose sensitivity, rate sensitivity, and potentiation) were similar in the 2 groups. Abdominal VAT, insulin resistance, and blood pressure were quantitatively interrelated (rho's of 0.39 to 0.47, P<0.02 or less). In newly found, untreated men with essential hypertension, fat is preferentially accumulated intraabdominally and intrathoracically. Such visceral adiposity is quantitatively related to both height of blood pressure and severity of insulin resistance, but has no impact on the dynamics of beta-cell function.
Comment in
- Mediastinal fat, insulin resistance, and hypertension.
Sharma AM. Sharma AM. Hypertension. 2004 Aug;44(2):117-8. doi: 10.1161/01.HYP.0000137993.70745.82. Epub 2004 Jul 12. Hypertension. 2004. PMID: 15249549 No abstract available.
Similar articles
- Visceral fat and beta cell function in non-diabetic humans.
Gastaldelli A, Sironi AM, Ciociaro D, Positano V, Buzzigoli E, Giannessi D, Lombardi M, Mari A, Ferrannini E. Gastaldelli A, et al. Diabetologia. 2005 Oct;48(10):2090-6. doi: 10.1007/s00125-005-1891-3. Epub 2005 Aug 6. Diabetologia. 2005. PMID: 16086140 - Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.
Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, Vettor R. Macor C, et al. Metabolism. 1997 Feb;46(2):123-9. doi: 10.1016/s0026-0495(97)90288-2. Metabolism. 1997. PMID: 9030815 - Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA. Gastaldelli A, et al. Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1. Gastroenterology. 2007. PMID: 17681171 - Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Wajchenberg BL, et al. Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21. doi: 10.1055/s-2002-38256. Horm Metab Res. 2002. PMID: 12660870 Review.
Cited by
- Role of body visceral fat in hypertension and dyslipidemia among the diabetic and nondiabetic ethnic population of Tripura-A comparative study.
Goswami B, Reang T, Sarkar S, Sengupta S, Bhattacharjee B. Goswami B, et al. J Family Med Prim Care. 2020 Jun 30;9(6):2885-2890. doi: 10.4103/jfmpc.jfmpc_187_20. eCollection 2020 Jun. J Family Med Prim Care. 2020. PMID: 32984144 Free PMC article. - Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging.
Bonekamp S, Ghosh P, Crawford S, Solga SF, Horska A, Brancati FL, Diehl AM, Smith S, Clark JM. Bonekamp S, et al. Int J Obes (Lond). 2008 Jan;32(1):100-11. doi: 10.1038/sj.ijo.0803696. Epub 2007 Aug 14. Int J Obes (Lond). 2008. PMID: 17700582 Free PMC article. Clinical Trial. - Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program.
Lingvay I, Mosenzon O, Brown K, Cui X, O'Neill C, Fernández Landó L, Patel H. Lingvay I, et al. Cardiovasc Diabetol. 2023 Mar 24;22(1):66. doi: 10.1186/s12933-023-01797-5. Cardiovasc Diabetol. 2023. PMID: 36964557 Free PMC article. - Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women.
Zhang ZQ, Deng J, He LP, Ling WH, Su YX, Chen YM. Zhang ZQ, et al. PLoS One. 2013 Aug 12;8(8):e70893. doi: 10.1371/journal.pone.0070893. eCollection 2013. PLoS One. 2013. PMID: 23951031 Free PMC article. - Obesity as an Early Symptom of the AMIS Syndrome.
Lautt WW, Wang HH. Lautt WW, et al. J Clin Med. 2014 Oct 28;3(4):1178-98. doi: 10.3390/jcm3041178. J Clin Med. 2014. PMID: 26237598 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous